Table 3.
Vaccine and injection supplies costs with and without measles second dose, pneumococcal, and rotavirus vaccines (2014 US$).
Antigen | Doses per person | Vaccine coverage of first dose | Vial size | Wastage in percent | Costs per dose (incl. freight) | Total vaccine costs | Injection supply costs | Total costs | % of total |
---|---|---|---|---|---|---|---|---|---|
Bacille Calmette Guerin | 1 | 95% | 20 | 50% | 0.15 | 185,495 | 52,669 | 238,164 | 1% |
Diphteria-Tetanus-Pertussis-HepB-Hib | 3 | 96% | 1 | 5% | 2.87 | 5,242,890 | 120,314 | 5,363,205 | 32% |
Measles | 1 | 85% | 10 | 40% | 0.29 | 245,002 | 40,073 | 285,075 | 2% |
Oral polio vaccine | 4 | 96% | 10 | 25% | 0.23 | 701,364 | – | 701,364 | 4% |
Tetanus toxoid | 2 | 74% | 10 | 25% | 0.12 | 172,084 | 77,881 | 249,966 | 1% |
Total before new vaccines | 6,546,835 | 290,937 | 6,837,773 | ||||||
Measles 2nd dose | 1 | 33% | 10 | 40% | 0.29 | 97,564 | 15,558 | 115,567 | 1% |
Pneumococcal conjugate | 3 | 96% | 2 | 5% | 3.61 | 6,766,366 | 120,314 | 7,073,884 | 42% |
Rotavirus | 2 | 96% | 1 | 5% | 2.21 | 2,757,647 | – | 2,832,528 | 17% |
Total with new vaccines | 16,168,412 | 411,252 | 16,859,752 | 100% |